European Commission authorizes Pfizer and BioNTech XFG-adapted COVID-19 vaccine in the European…
Pfizer and BioNTech SE announced that the European Commission (EC) has granted marketing authorization for the companies’…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
BioNTech
Pfizer, BioNTech give update on mRNA-based combination vaccine programme
The combination candidate consists of Pfizer’s mRNA-based influenza vaccine candidate with the companies’ licensed COVID-19…
MHRA approves Pfizer/BioNTech’s adapted COVID-19 vaccine for Omicron XBB.1.5
The vaccine has been approved for use in individuals from six months of age
BioNTech to lead $2 bn mRNA-based oncology therapy market despite challenges: GlobalData
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials, predominantly targeting solid tumors…
BioNTech, Roche’s pancreatic cancer treatment bodes well for future: Nature
Half of the trial participants had developed T cells that can potentially recognise cancerous cells and stop them from re-emerging
GlobalData upgrades Pfizer’s COVID-19 vaccine sales forecast to $37 bn in 2022
In 2023, Comirnaty is expected to have an even better year, with sales forecasts up by 16 per cent
BioNTech sees UK trials on cancer vaccines starting this year: Ugur Sahin
The company wants these therapies, which are based on mRNA technology similar to the one that underpins its COVID-19 vaccine, to…
BioNTech to invest $43 mn in German facility for mRNA vaccine
The clinical-scale plant has been operational since August 2022 while the commercial-scale one should be ready by end-2023
Israel says has not found a link between Pfizer COVID shot and stroke
The US Food and Drug Administration (USFDA) and the Centres for Disease Control and Prevention said that a safety monitoring…
BioNTech buys InstaDeep
BioNTech is to pay 362 million pounds upfront, in a mix of cash and an unspecified number of BioNTech shares, and up to 200…